Antibodies reactive with Candida albicans mannoprotein are found in sera of most normal adults. Often referred to as """"""""natural"""""""" antibodies, the amount of anti-mannan antibody found in a population of donors is normally distributed ; some individuals have little or not antibody, other individuals have remarkably high titers. Little is known about the fine epitope specificity or biological activity of naturally-occurring antimannan antibody. """"""""Natural"""""""" antimannan IgG may be a first-line defenses against systemic Candida infection. The goal of the Candida: Protective Immunity MRU is to establish a knowledge base essential for development of a Candida vaccine. Naturally- occurring antimannan antibodies are a key issue that must be considered if active immunization, be it by a protein antigen (Edwards and Mitchell projects) or an epitope derived from a polysaccharide antigen (Cutler project), is to be successful. Moreover, the presence of these antimannan antibodies and the ability to affinity purify hundreds of milligrams of antibody from human plasma enables an evaluation of the function, including protective efficacy, of human antimannan antibodies. The central hypotheses is that naturally-occurring human antimannan antibodies have biological activities that influence host resistance to disseminated candidiasis. Moreover, these biological activities may be dependent on the epitope specificity of naturally occurring antimannan antibodies to activation of the classical and alternative complement pathways; iii) assess the opsonic activity of naturally-occurring antimannan antibodies; iv) determine whether naturally-occurring anti-Candida antibodies are productive in murine models of candiasis, and v) assess the effects of circulating """"""""natural"""""""" antimannan antibodies on the efficacy of immunoprotective strategies developed by other components of the Mycology Research Unit.

Project Start
1999-04-15
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
City
Torrance
State
CA
Country
United States
Zip Code
90502
Boxx, Gayle M; Kozel, Thomas R; Nishiya, Casey T et al. (2010) Influence of mannan and glucan on complement activation and C3 binding by Candida albicans. Infect Immun 78:1250-9
Boxx, Gayle M; Nishiya, Casey T; Kozel, Thomas R et al. (2009) Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Mol Immunol 46:473-80
Zhang, Mason X; Bohlman, M Charlotte; Itatani, Carol et al. (2006) Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect Immun 74:362-9
Lillegard, Joseph B; Sim, Robert B; Thorkildson, Peter et al. (2006) Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J Infect Dis 193:1589-97
Toenjes, Kurt A; Munsee, Suzanne M; Ibrahim, Ashraf S et al. (2005) Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 49:963-72
Cutler, J E (2005) Defining criteria for anti-mannan antibodies to protect against candidiasis. Curr Mol Med 5:383-92
Granger, Bruce L; Flenniken, Michelle L; Davis, Dana A et al. (2005) Yeast wall protein 1 of Candida albicans. Microbiology 151:1631-44
Ibrahim, Ashraf S; Spellberg, Brad J; Avenissian, Valentina et al. (2005) Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 73:999-1005
Spellberg, Brad J; Ibrahim, Ashraf S; Avenissian, Valentina et al. (2005) The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice. Infect Immun 73:6191-3
VandenBerg, Alysia L; Ibrahim, Ashraf S; Edwards Jr, John E et al. (2004) Cdc42p GTPase regulates the budded-to-hyphal-form transition and expression of hypha-specific transcripts in Candida albicans. Eukaryot Cell 3:724-34

Showing the most recent 10 out of 63 publications